Stereotaxis, a developer of robotic technologies for the treatment of cardiac arrhythmias, says it has reached a significant milestone of over 400 scientific publications now documenting the clinical benefits of Stereotaxis robotic technology.
A complete, searchable database of all publications is available on the company’s website, at this link.
David Fischel, chairman and CEO of Stereotaxis, says: “The clinical benefits of Robotic Magnetic Navigation have been extensively validated in high-quality clinical literature and in the real-world treatment of over one-hundred-thousand arrhythmia patients. [Read more…] about Stereotaxis robotic technology referenced in ‘over 400 scientific publications’